Disposition of enrofloxacin in red-tailed hawks (Buteo jamaicensis) and great horned owls (Bubo virginianus) after a single oral, intramuscular, or intravenous dose

Lisa Harrenstien, Lisa A. Tell, Richard Vulliet, Martha Needham, Chris M. Brandt, Angela Brondos, Bret Stedman, Philip H. Kass

Research output: Contribution to journalArticle

21 Citations (Scopus)

Abstract

Enrofloxacin is a fluoroquinolone antibiotic that is effective against many of the common gram-negative bacterial pathogens in raptors. This 3-period crossover study was designed to compare the pharmacokinetics of enrofloxacin after oral, intramuscular, or intravenous administration in red-tailed hawks (Buteo jamaicensis; n = 8) and great horned owls (Bubo virginianus; n = 5). In each study period, birds received a single dose of an injectable formulation of enrofloxacin (15 mg/kg) by 1 of these 3 routes. Oral administration was accomplished by force-feeding each bird a small freshly killed mouse that had received an intraperitoneal injection of enrofloxacin (in-prey). Intramuscular injections were divided into 2 sites in the pectoral musculature. Serial plasma samples were taken before administration and at 0.25, 0.5, 1, 2, 4, 8, 12, 24, and 48 hours after administration. Oral administration resulted in plasma concentrations of enrofloxacin that peaked at 4-8 hours in both species. Plasma concentrations remained at >1 μg/ml until at least 18 hours after administration, although an initial lag time of approximately 2-8 hours occurred for absorption from the gastrointestinal tract. Intramuscular administration resulted in plasma concentrations that peaked at 0.5-2 hours; enrofloxacin levels remained at >1 μg/ml for at least 15 hours. After intravenous administration to red-tailed hawks, enrofloxacin levels remained at >1 μg/ml for at least 15 hours. Two great horned owls showed acute weakness, bradycardia, and peripheral vasoconstriction during intravenous injection. These clinical signs resolved within 1-3 hours with supportive therapy; however, the intravenous route was not evaluated for the other 3 owls. We conclude that oral (in-prey) and intramuscular routes are reliable means of administration of injectable enrofloxacin in red-tailed hawks and great horned owls, using a dosage of 15 mg/kg q24h. Intravenous administration of enrofloxacin can be performed with caution in red-tailed hawks but should not be attempted in great horned owls.

Original languageEnglish (US)
Pages (from-to)28-236
Number of pages209
JournalJournal of Avian Medicine and Surgery
Volume14
Issue number4
StatePublished - 2000
Externally publishedYes

Fingerprint

Hawks
Bubo virginianus
Strigiformes
Buteo jamaicensis
enrofloxacin
mouth
dosage
intravenous injection
intramuscular injection
Intravenous Administration
Oral Administration
oral administration
Birds
Raptors
forced feeding
Injections
fluoroquinolones
vasoconstriction
birds
Intramuscular Injections

Keywords

  • Adverse reactions
  • Bubo virginianus
  • Buteo jamaicensis
  • Enrofloxacin
  • Great horned owl
  • Red-tailed hawk
  • Single-dose pharmacokinetics

ASJC Scopus subject areas

  • veterinary(all)

Cite this

Disposition of enrofloxacin in red-tailed hawks (Buteo jamaicensis) and great horned owls (Bubo virginianus) after a single oral, intramuscular, or intravenous dose. / Harrenstien, Lisa; Tell, Lisa A.; Vulliet, Richard; Needham, Martha; Brandt, Chris M.; Brondos, Angela; Stedman, Bret; Kass, Philip H.

In: Journal of Avian Medicine and Surgery, Vol. 14, No. 4, 2000, p. 28-236.

Research output: Contribution to journalArticle

Harrenstien, L, Tell, LA, Vulliet, R, Needham, M, Brandt, CM, Brondos, A, Stedman, B & Kass, PH 2000, 'Disposition of enrofloxacin in red-tailed hawks (Buteo jamaicensis) and great horned owls (Bubo virginianus) after a single oral, intramuscular, or intravenous dose', Journal of Avian Medicine and Surgery, vol. 14, no. 4, pp. 28-236.
Harrenstien, Lisa ; Tell, Lisa A. ; Vulliet, Richard ; Needham, Martha ; Brandt, Chris M. ; Brondos, Angela ; Stedman, Bret ; Kass, Philip H. / Disposition of enrofloxacin in red-tailed hawks (Buteo jamaicensis) and great horned owls (Bubo virginianus) after a single oral, intramuscular, or intravenous dose. In: Journal of Avian Medicine and Surgery. 2000 ; Vol. 14, No. 4. pp. 28-236.
@article{38c6f15534834808bb2a5c00ddcdaff3,
title = "Disposition of enrofloxacin in red-tailed hawks (Buteo jamaicensis) and great horned owls (Bubo virginianus) after a single oral, intramuscular, or intravenous dose",
abstract = "Enrofloxacin is a fluoroquinolone antibiotic that is effective against many of the common gram-negative bacterial pathogens in raptors. This 3-period crossover study was designed to compare the pharmacokinetics of enrofloxacin after oral, intramuscular, or intravenous administration in red-tailed hawks (Buteo jamaicensis; n = 8) and great horned owls (Bubo virginianus; n = 5). In each study period, birds received a single dose of an injectable formulation of enrofloxacin (15 mg/kg) by 1 of these 3 routes. Oral administration was accomplished by force-feeding each bird a small freshly killed mouse that had received an intraperitoneal injection of enrofloxacin (in-prey). Intramuscular injections were divided into 2 sites in the pectoral musculature. Serial plasma samples were taken before administration and at 0.25, 0.5, 1, 2, 4, 8, 12, 24, and 48 hours after administration. Oral administration resulted in plasma concentrations of enrofloxacin that peaked at 4-8 hours in both species. Plasma concentrations remained at >1 μg/ml until at least 18 hours after administration, although an initial lag time of approximately 2-8 hours occurred for absorption from the gastrointestinal tract. Intramuscular administration resulted in plasma concentrations that peaked at 0.5-2 hours; enrofloxacin levels remained at >1 μg/ml for at least 15 hours. After intravenous administration to red-tailed hawks, enrofloxacin levels remained at >1 μg/ml for at least 15 hours. Two great horned owls showed acute weakness, bradycardia, and peripheral vasoconstriction during intravenous injection. These clinical signs resolved within 1-3 hours with supportive therapy; however, the intravenous route was not evaluated for the other 3 owls. We conclude that oral (in-prey) and intramuscular routes are reliable means of administration of injectable enrofloxacin in red-tailed hawks and great horned owls, using a dosage of 15 mg/kg q24h. Intravenous administration of enrofloxacin can be performed with caution in red-tailed hawks but should not be attempted in great horned owls.",
keywords = "Adverse reactions, Bubo virginianus, Buteo jamaicensis, Enrofloxacin, Great horned owl, Red-tailed hawk, Single-dose pharmacokinetics",
author = "Lisa Harrenstien and Tell, {Lisa A.} and Richard Vulliet and Martha Needham and Brandt, {Chris M.} and Angela Brondos and Bret Stedman and Kass, {Philip H.}",
year = "2000",
language = "English (US)",
volume = "14",
pages = "28--236",
journal = "Journal of Avian Medicine and Surgery",
issn = "1082-6742",
publisher = "Association of Avian Veterinarians",
number = "4",

}

TY - JOUR

T1 - Disposition of enrofloxacin in red-tailed hawks (Buteo jamaicensis) and great horned owls (Bubo virginianus) after a single oral, intramuscular, or intravenous dose

AU - Harrenstien, Lisa

AU - Tell, Lisa A.

AU - Vulliet, Richard

AU - Needham, Martha

AU - Brandt, Chris M.

AU - Brondos, Angela

AU - Stedman, Bret

AU - Kass, Philip H.

PY - 2000

Y1 - 2000

N2 - Enrofloxacin is a fluoroquinolone antibiotic that is effective against many of the common gram-negative bacterial pathogens in raptors. This 3-period crossover study was designed to compare the pharmacokinetics of enrofloxacin after oral, intramuscular, or intravenous administration in red-tailed hawks (Buteo jamaicensis; n = 8) and great horned owls (Bubo virginianus; n = 5). In each study period, birds received a single dose of an injectable formulation of enrofloxacin (15 mg/kg) by 1 of these 3 routes. Oral administration was accomplished by force-feeding each bird a small freshly killed mouse that had received an intraperitoneal injection of enrofloxacin (in-prey). Intramuscular injections were divided into 2 sites in the pectoral musculature. Serial plasma samples were taken before administration and at 0.25, 0.5, 1, 2, 4, 8, 12, 24, and 48 hours after administration. Oral administration resulted in plasma concentrations of enrofloxacin that peaked at 4-8 hours in both species. Plasma concentrations remained at >1 μg/ml until at least 18 hours after administration, although an initial lag time of approximately 2-8 hours occurred for absorption from the gastrointestinal tract. Intramuscular administration resulted in plasma concentrations that peaked at 0.5-2 hours; enrofloxacin levels remained at >1 μg/ml for at least 15 hours. After intravenous administration to red-tailed hawks, enrofloxacin levels remained at >1 μg/ml for at least 15 hours. Two great horned owls showed acute weakness, bradycardia, and peripheral vasoconstriction during intravenous injection. These clinical signs resolved within 1-3 hours with supportive therapy; however, the intravenous route was not evaluated for the other 3 owls. We conclude that oral (in-prey) and intramuscular routes are reliable means of administration of injectable enrofloxacin in red-tailed hawks and great horned owls, using a dosage of 15 mg/kg q24h. Intravenous administration of enrofloxacin can be performed with caution in red-tailed hawks but should not be attempted in great horned owls.

AB - Enrofloxacin is a fluoroquinolone antibiotic that is effective against many of the common gram-negative bacterial pathogens in raptors. This 3-period crossover study was designed to compare the pharmacokinetics of enrofloxacin after oral, intramuscular, or intravenous administration in red-tailed hawks (Buteo jamaicensis; n = 8) and great horned owls (Bubo virginianus; n = 5). In each study period, birds received a single dose of an injectable formulation of enrofloxacin (15 mg/kg) by 1 of these 3 routes. Oral administration was accomplished by force-feeding each bird a small freshly killed mouse that had received an intraperitoneal injection of enrofloxacin (in-prey). Intramuscular injections were divided into 2 sites in the pectoral musculature. Serial plasma samples were taken before administration and at 0.25, 0.5, 1, 2, 4, 8, 12, 24, and 48 hours after administration. Oral administration resulted in plasma concentrations of enrofloxacin that peaked at 4-8 hours in both species. Plasma concentrations remained at >1 μg/ml until at least 18 hours after administration, although an initial lag time of approximately 2-8 hours occurred for absorption from the gastrointestinal tract. Intramuscular administration resulted in plasma concentrations that peaked at 0.5-2 hours; enrofloxacin levels remained at >1 μg/ml for at least 15 hours. After intravenous administration to red-tailed hawks, enrofloxacin levels remained at >1 μg/ml for at least 15 hours. Two great horned owls showed acute weakness, bradycardia, and peripheral vasoconstriction during intravenous injection. These clinical signs resolved within 1-3 hours with supportive therapy; however, the intravenous route was not evaluated for the other 3 owls. We conclude that oral (in-prey) and intramuscular routes are reliable means of administration of injectable enrofloxacin in red-tailed hawks and great horned owls, using a dosage of 15 mg/kg q24h. Intravenous administration of enrofloxacin can be performed with caution in red-tailed hawks but should not be attempted in great horned owls.

KW - Adverse reactions

KW - Bubo virginianus

KW - Buteo jamaicensis

KW - Enrofloxacin

KW - Great horned owl

KW - Red-tailed hawk

KW - Single-dose pharmacokinetics

UR - http://www.scopus.com/inward/record.url?scp=18544384719&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=18544384719&partnerID=8YFLogxK

M3 - Article

VL - 14

SP - 28

EP - 236

JO - Journal of Avian Medicine and Surgery

JF - Journal of Avian Medicine and Surgery

SN - 1082-6742

IS - 4

ER -